Cormorant Asset Management, LP
Q3 2026 13F filing
Updated 6 days ago60 disclosed positions worth $1.5B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PARABILIS MEDICINES INC | $149M | 4.62M | 10.01% | — |
| 2 | P PRAXIS PRECISION MEDICINES I | $145.6M | 500.0K | 9.78% | — |
| 3 | R RAPPORT THERAPEUTICS INC | $82.6M | 2.46M | 5.54% | — |
| 4 | E EDGEWISE THERAPEUTICS INC | $75.5M | 1.86M | 5.07% | — |
| 5 | ? N/A BRIDGEBIO ONCOLOGY THERAPEUT | $73.3M | 17.88M | 4.92% | — |
| 6 | E ERASCA INC | $73.3M | 5.00M | 4.92% | — |
| 7 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $67.4M | 3.61M | 4.52% | — |
| 8 | A ADLAI NORTYE GROUP LTD | $63.7M | 3.98M | 4.27% | — |
| 9 | D DIANTHUS THERAPEUTICS INC | $44M | 500.0K | 2.96% | — |
| 10 | A ABIVAX SA | $42.1M | 425.0K | 2.83% | — |
| 11 | D BRIGHT MINDS BIOSCIENCES INC | $39.9M | 800.0K | 2.68% | — |
| 12 | ? N/A ELECTRA THERAPEUTICS INC | $37.9M | 3.37M | 2.54% | — |
| 13 | M MOONLAKE IMMUNOTHERAPEUTICS | $33.4M | 2.86M | 2.24% | — |
| 14 | O ORUKA THERAPEUTICS INC | $33.3M | 400.0K | 2.24% | — |
| 15 | ? N/A ATTOVIA THERAPEUTICS INC | $30.7M | 1.79M | 2.06% | — |
| 16 | F FAETH THERAPEUTICS INC | $30.6M | 1.03M | 2.05% | — |
| 17 | ? N/A LATIGO BIOTHERAPEUTICS INC | $30.3M | 1.82M | 2.04% | — |
| 18 | A AGOMAB THERAPEUTICS NV | $27.4M | 2.47M | 1.84% | — |
| 19 | I OPUS GENETICS INC | $26.6M | 5.50M | 1.79% | — |
| 20 | ? N/A CLIMB BIO INC | $24.2M | 2.11M | 1.62% | — |
| 21 | F FREENOME INC | $22.5M | 1.43M | 1.51% | — |
| 22 | M MBX BIOSCIENCES INC | $22M | 375.0K | 1.48% | — |
| 23 | B BIOHAVEN LTD | $20.2M | 1.51M | 1.35% | — |
| 24 | A ADARX PHARMACEUTICALS INC | $19.2M | 962.9K | 1.29% | — |
| 25 | ? N/A EYEPOINT INC | $18.8M | 5.75M | 1.26% | — |
| 26 | T TANGO THERAPEUTICS INC | $17.5M | 700.0K | 1.17% | — |
| 27 | ? N/A DAMORA THERAPEUTICS INC | $17M | 800.0K | 1.14% | — |
| 28 | B BRIDGEBIO PHARMA INC | $16.4M | 250.0K | 1.10% | — |
| 29 | ? N/A CUE BIOPHARMA INC | $16.2M | 625.3K | 1.09% | — |
| 30 | C CORBUS PHARMACEUTICALS HLDGS | $16M | 2.34M | 1.07% | — |
| 31 | B BIOAGE LABS INC | $15.9M | 2.24M | 1.07% | — |
| 32 | A ALUMIS INC | $15.3M | 2.08M | 1.03% | — |
| 33 | O OLEMA PHARMACEUTICALS INC | $15.1M | 1.75M | 1.02% | — |
| 34 | P PHARVARIS N V | $14.3M | 450.0K | 0.96% | — |
| 35 | ? N/A HELIX ACQUISITION CORP III | $13.8M | 1.30M | 0.93% | — |
| 36 | S SPYRE THERAPEUTICS INC | $11.1M | 125.0K | 0.75% | — |
| 37 | D DEFINIUM THERAPEUTICS INC | $10.5M | 275.0K | 0.70% | — |
| 38 | A ACLARIS THERAPEUTICS INC | $9.2M | 1.75M | 0.62% | — |
| 39 | A AMYLYX PHARMACEUTICALS INC | $8.7M | 300.0K | 0.59% | — |
| 40 | C CABALETTA BIO INC | $8.6M | 4.50M | 0.58% | — |
| 41 | I INHIBRX BIOSCIENCES INC | $5M | 50.0K | 0.34% | — |
| 42 | K KAILERA THERAPEUTICS INC | $4.6M | 400.0K | 0.31% | — |
| 43 | J JADE BIOSCIENCES INC | $4.2M | 300.0K | 0.28% | — |
| 44 | ? N/A IBIO INC | $4.2M | 3.57M | 0.28% | — |
| 45 | T TARSUS PHARMACEUTICALS INC | $3.9M | 50.0K | 0.26% | — |
| 46 | R ROIVANT SCIENCES LTD | $3.7M | 100.0K | 0.25% | — |
| 47 | E ENLIVEN THERAPEUTICS INC | $3.4M | 75.0K | 0.23% | — |
| 48 | A ASCENDIS PHARMA A/S | $3.4M | 15.0K | 0.23% | — |
| 49 | O ODYSSEY THERAPEUTICS INC | $2.8M | 125.0K | 0.19% | — |
| 50 | N NEWAMSTERDAM PHARMA COMPANY | $2.4M | 100.0K | 0.16% | — |